Myalgic phenotype and preserved muscle strength in adult-onset acid maltase deficiency

Neuromuscular Disorders

Volumn 22, Issue 8, 2012, Pages 763-766

  Jones Jr , Lyell K ^a   Liewluck, Teerin ^a   Gavrilova, Ralitza H ^a  

^a MAYO CLINIC   (United States)

Author keywords

Acid maltase deficiency; Glycogen storage disease II; Myalgia; Myofascial pain; Pompe disease

Indexed keywords

ACID PHOSPHATASE; ALPHA GLUCOSIDASE; CREATINE KINASE;

ADL DISABILITY; ADULT; ADULT ONSET ACID MALTASE DEFICIENCY; ARTICLE; CASE REPORT; CREATINE KINASE BLOOD LEVEL; FEMALE; GAA GENE; GENE; GENE MUTATION; HUMAN; HUMAN TISSUE; LUNG FUNCTION TEST; LYSOSOME STORAGE DISEASE; MUSCLE BIOPSY; MUSCLE CRAMP; MUSCLE STRENGTH; MUSCLE WEAKNESS; MYALGIA; MYOPATHY; MYOTONIC DYSTROPHY; OBESITY; PRIORITY JOURNAL; VITAL CAPACITY;

ALPHA-GLUCOSIDASES; COMORBIDITY; CREATINE KINASE; FEMALE; GLYCOGEN STORAGE DISEASE TYPE II; HUMANS; MIDDLE AGED; MUSCLE STRENGTH; MUSCLE WEAKNESS; MUSCLE, SKELETAL; PHENOTYPE; RESPIRATORY INSUFFICIENCY;

EID: 84863862669     PISSN: 09608966     EISSN: 18732364     Source Type: Journal    
DOI: 10.1016/j.nmd.2012.02.003     Document Type: Article

References (19)

1. van den Hout H.M., Hop W., van Diggelen O.P., et al. The natural course of infantile Pompe's disease: 20 original cases compared with 133 cases from the literature. Pediatrics 2003, 112:332-340.
2. Kroos M., Pomponio R.J., van Vliet L., et al. Update of the Pompe disease mutation database with 107 sequence variants and a format for severity rating. Hum Mutat 2008, 29:E13-E26.
3. Kishnani P.S., Corzo D., Nicolino M., et al. Recombinant human acid [alpha]-glucosidase: major clinical benefits in infantile-onset Pompe disease. Neurology 2007, 68:99-109.
4. van der Ploeg A.T., Clemens P.R., Corzo D., et al. A randomized study of alglucosidase alfa in late-onset Pompe's disease. N Engl J Med 2010, 362:1396-1406.
5. Engel A.G., Dale A.J. Autophagic glycogenosis of late onset with mitochondrial abnormalities: light and electron microscopic observations. Mayo Clin Proc 1968, 43:233-279.
6. Wokke J.H., Escolar D.M., Pestronk A., et al. Clinical features of late-onset Pompe disease: a prospective cohort study. Muscle Nerve 2008, 38:1236-1245.
7. Hagemans M.L., Winkel L.P., Van Doorn P.A., et al. Clinical manifestation and natural course of late-onset Pompe's disease in 54 Dutch patients. Brain 2005, 128:671-677.
8. Muller-Felber W., Horvath R., Gempel K., et al. Late onset Pompe disease: clinical and neurophysiological spectrum of 38 patients including long-term follow-up in 18 patients. Neuromuscul Disord 2007, 17:698-706.
9. Huie M.L., Chen A.S., Tsujino S., et al. Aberrant splicing in adult onset glycogen storage disease type II (GSDII): molecular identification of an IVS1 (-13T→G) mutation in a majority of patients and a novel IVS10 (+1GT→CT) mutation. Hum Mol Genet 1994, 3:2231-2236.
10. Schoser B.G., Muller-Hocker J., Horvath R., et al. Adult-onset glycogen storage disease type 2: clinico-pathological phenotype revisited. Neuropathol Appl Neurobiol 2007, 33:544-559.
11. Martiniuk F., Chen A., Mack A., et al. Carrier frequency for glycogen storage disease type II in New York and estimates of affected individuals born with the disease. Am J Med Genet 1998, 79:69-72.
12. Ausems M.G., Verbiest J., Hermans M.P., et al. Frequency of glycogen storage disease type II in The Netherlands: implications for diagnosis and genetic counselling. Eur J Hum Genet 1999, 7:713-716.
13. Chien Y.H., Lee N.C., Thurberg B.L., et al. Pompe disease in infants: improving the prognosis by newborn screening and early treatment. Pediatrics 2009, 124:e1116-e1125.
14. Weir P.T., Harlan G.A., Nkoy F.L., et al. The incidence of fibromyalgia and its associated comorbidities: a population-based retrospective cohort study based on International Classification of Diseases, 9th Revision codes. J Clin Rheumatol 2006, 12:124-128.
15. George A., Schneider-Gold C., Zier S., Reiners K., Sommer C. Musculoskeletal pain in patients with myotonic dystrophy type 2. Arch Neurol 2004, 61:1938-1942.
16. Engel A.G., Hirschhorn R., Huie M.L. Acid maltase deficiency. Myology 2004, 1559-1586. McGraw-Hill, New York. Third ed. A.G. Engel, C. Franzini-Armstrong (Eds.).
17. Vielhaber S., Brejova A., Debska-Vielhaber G., et al. 24-months results in two adults with Pompe disease on enzyme replacement therapy. Clin Neurol Neurosurg 2011, 113:350-357.
18. Van der Beek N.A., Hagemans M.L., Reuser A.J., et al. Rate of disease progression during long-term follow-up of patients with late-onset Pompe disease. Neuromuscul Disord 2009, 19:113-117.
19. Yang C.C., Chien Y.H., Lee N.C., et al. Rapid progressive course of later-onset Pompe disease in Chinese patients. Mol Genet Metab 2011, 104:284-288.